Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:21:00 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



Q:CYTK - CYTOKINETICS INC - http://www.cytokinetics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYTK - Q0.364.28·64.370.264.39+1.021.6117.07,3981,35664.33  64.61  63.57110.25  25.9811:03:02Apr 2915 min RT 2¢

Recent Trades - Last 10 of 1356
Time ETExPriceChangeVolume
11:03:12Q64.34930.97932
11:03:08Q64.320.957
11:03:06Q64.2850.9156
11:03:02Q64.34870.97872
11:02:57Q64.340.972
11:02:43Q64.33220.96222
11:02:34Q64.35590.98592
11:02:34Q64.340.979
11:02:15Q64.35450.98452
11:02:07Q64.330.9610

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-29 16:00U:CYTKNews ReleaseCytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
2024-04-24 16:00U:CYTKNews ReleaseCytokinetics to Announce First Quarter Results on May 8, 2024
2024-04-10 07:30U:CYTKNews ReleaseCytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
2024-04-05 07:30U:CYTKNews ReleaseCytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
2024-04-02 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-04-01 16:00U:CYTKNews ReleaseCytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
2024-03-25 08:15U:CYTKNews ReleaseCytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
2024-03-04 16:00U:CYTKNews ReleaseCytokinetics to Participate in March Investor Conferences
2024-03-01 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-02-29 07:30U:CYTKNews ReleaseCytokinetics Joins Global Initiative to Recognize International Rare Disease Day
2024-02-28 07:30U:CYTKNews ReleaseCytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials
2024-02-27 16:00U:CYTKNews ReleaseCytokinetics Reports Fourth Quarter 2023 Financial Results
2024-02-13 16:00U:CYTKNews ReleaseCytokinetics to Announce Fourth Quarter Results on February 27, 2024
2024-02-06 16:00U:CYTKNews ReleaseCytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2024-01-29 07:30U:CYTKNews ReleaseCytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program
2024-01-25 07:30U:CYTKNews ReleaseCytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten
2024-01-18 13:00U:CYTKNews ReleaseCytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024
2024-01-03 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-01-02 16:00U:CYTKNews ReleaseCytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference